Springfield, NJ, United States of America

Kristen S Labazzo

USPTO Granted Patents = 8 (Patent Applications = 12)

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 13 (Patent Applications = 16)

Average Co-Inventor Count = 7.5

ph-index = 3

Forward Citations = 57(Granted Patents)

Company Filing History:

5 out of 64

Anthrogenesis Corporation

Antrhogenesis Corporation

patent

Years Active: 2013-2019

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10494607 - CD34,CD45placental stem cell-enriched cell populations (2019-12-03),

2. 10105399 - Methods and compositions for treatment of bone defects with placental cell populations (2018-10-23),

3. 9339520 - Methods and compositions for treatment of bone defects with placental cell populations (2016-05-17),

4. 9254302 - Angiogenesis using placental stem cells (2016-02-09),

5. 9198938 - Amnion derived adherent cells (2015-12-01),

6. 8728805 - Methods and compositions for treatment of bone defects with placental cell populations (2014-05-20),

7. 8562972 - Methods and compositions for treatment of bone defects with placental cell populations (2013-10-22),

8. 8367409 - Amnion derived adherent cells (2013-02-05),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I will provide you with an article about inventor Kristen S Labazzo based on the given data.

Title: The Innovative Work of Kristen S Labazzo: Pioneering Advancements in Stem Cell Technology

Introduction:

Kristen S Labazzo, a talented inventor based in Springfield, NJ (US), has made significant contributions to the field of regenerative medicine through her groundbreaking work in stem cell research. With a total of 8 patents to her name, Kristen is at the forefront of developing novel therapies using placental stem cells.

Latest Patents:

Kristen's latest patents showcase her expertise in harnessing the potential of placental stem cells for therapeutic applications. One notable patent, titled "CD34, CD45 placental stem cell-enriched cell populations," focuses on the production of hepatocytes from placental stem cells for the treatment of liver disorders. Additionally, her work extends to cartilage repair and bone defect treatments, demonstrating the versatility of placental stem cells in regenerative medicine.

Career Highlights:

Throughout her career, Kristen has been associated with renowned companies in the biotechnology sector, including Anthrogenesis Corporation and Celularity Inc. Her tenure at these organizations has been marked by innovative research and cutting-edge developments in stem cell technology, solidifying her reputation as a trailblazer in the field.

Collaborations:

Kristen has collaborated with esteemed professionals in the field, including James W Edinger and Jia-Lun Wang. These collaborations have resulted in the advancement of stem cell research, paving the way for new treatment modalities and therapeutic interventions in regenerative medicine.

Conclusion:

In conclusion, Kristen S Labazzo's multidisciplinary approach to stem cell research has led to groundbreaking innovations in the field of regenerative medicine. Her patents not only demonstrate her technical prowess but also underscore her commitment to improving healthcare outcomes through the application of cutting-edge technologies. Kristen's contributions are set to have a lasting impact on the field, offering new hope for patients suffering from a range of medical conditions.

This text is generated by artificial intelligence and may not be accurate.